Testing effectiveness (Phase 2)Study completedNCT04474470
What this trial is testing
Evaluate NT219 Alone and in Combination with ERBITUX® (Cetuximab) in Adults with Advanced Solid Tumors and Head and Neck Cancer
Who this might be right for
Solid Tumor, AdultSquamous Cell Carcinoma of Head and NeckColorectal Adenocarcinoma+3 more
TyrNovo Ltd. 52